METRO FY Adj. EBITDA To Be At Upper End Of Guidance Range - Quick Facts

METRO (MTTWF.PK) said, after a strong recovery in the second half, the company finished the fiscal year at the upper end of the sales guidance. The sales were flat or down 0.4% adjusted for first time consolidations. Due to negative currency effects, especially in Turkey and Russia, sales were down 3.4% to 24.8 billion euros. The adjusted EBITDA is also expected to reach the upper end of the guidance range.

According to preliminary and unaudited figures, fourth quarter sales increased by 9.5% to 7.1 billion euros. Sales in local currency were up 9.9%. The Group noted that the sales in Western and Eastern Europe were above pre-pandemic level.

Steffen Greubel, CEO of METRO AG, said: "It shows once again that our targeted investments in market share gains as well as service and product quality are paying off. Therefore, we will continue to invest in growth, among other things by expanding our sales force."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Privately-held biotechnology company On Target Laboratories, Inc. announce that the U.S. Food and Drug Administration or FDA, has approved Cytalux (pafolacianine) for adult patients with ovarian cancer as an adjunct for intraoperative identification of malignant lesions. Cytalux is the first targeted fluorescent imaging agent that illuminates ovarian cancer intraoperatively. The Federal Trade Commission or FTC has ordered Walmart, Amazon, Kroger and certain other large wholesalers and suppliers to provide information to help it study causes of supply chain disruptions. The agency has launched an inquiry to find the reasons for empty shelves and exorbitant prices. Along with Walmart, Amazon.com, and Kroger, the order has been sent to C&S Wholesale Grocers, Associated.. Covid vaccine maker Moderna Inc.'s Chief Executive Stéphane Bancel has predicted that existing COVID-19 vaccines will be much less effective against Omicron than earlier strains, according to the Financial Times.
Follow RTT